Blog

Jun 18, 2019

Google backs a bid to use CRISPR to prevent heart disease

Posted by in categories: bioengineering, biotech/medical, computing, food, genetics, health

Ever wonder why some fortunate people eat chips, don’t exercise, and still don’t get clogged arteries? It could be because they’ve got lucky genes.

Now Alphabet (Google’s parent company) is bankrolling a startup company that plans to use gene editing to spread fortunate DNA variations with “one-time” injections of the gene-editing tool CRISPR.

Heart doctors involved say the DNA-tweaking injections could “confer lifelong protection” against heart disease.

Comments are closed.